Get the Stockscreener App
28.77
0.03%
0.010
After Hours:
28.77
Verona Pharma Plc Adr stock is traded at $28.77, with a volume of 820.21K.
It is up +0.03% in the last 24 hours and up +4.69% over the past month.
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
See More
Previous Close:
$28.76
Open:
$28.6
24h Volume:
820.21K
Relative Volume:
0.61
Market Cap:
$2.33B
Revenue:
-
Net Income/Loss:
$-125.45M
P/E Ratio:
-51.37
EPS:
-0.56
Net Cash Flow:
$-53.89M
1W Performance:
-2.80%
1M Performance:
+4.69%
6M Performance:
+78.81%
1Y Performance:
+76.50%
1-Day Range:
$28.36
$29.40
1-Week Range:
$27.54
$29.99
52-Week Range:
$11.39
$30.73
Verona Pharma Plc Adr Stock (VRNA) Company Profile
Name
Verona Pharma Plc Adr
Sector
Industry
Phone
011-44-0-2032834200
Address
3 MORE LONDON RIVERSIDE, LONDON
Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-23 | Resumed | Jefferies | Buy |
| Sep-19-22 | Resumed | Wedbush | Outperform |
| Aug-26-22 | Initiated | Piper Sandler | Overweight |
| Sep-13-21 | Initiated | H.C. Wainwright | Buy |
| Aug-25-20 | Initiated | Jefferies | Buy |
| Aug-10-20 | Initiated | Canaccord Genuity | Buy |
| Apr-18-19 | Initiated | BTIG Research | Buy |
View All
Verona Pharma Plc Adr Stock (VRNA) Latest News
Market Momentum Report: Verona Pharma Plc ADR (VRNA)’s Positive Close at 28.76 - The Dwinnex
Verona Pharma's SWOT analysis: stock soars on Ohtuvayre approval, COPD market potential - Investing.com
Verona Pharma Plc ADR [NASDAQ: VRNA] Sees Decrease in Stock Value - Knox Daily
The growth track for Verona Pharma Plc ADR (VRNA) has changed recently - SETE News
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
Investor’s Delight: Verona Pharma Plc ADR (VRNA) Closes Weak at 29.60, Down -1.30 - The Dwinnex
Does Verona Pharma Plc ADR (NASDAQ: VRNA) Still Look Hot This Week? - Stocks Register
Verona Pharma Plc ADR (VRNA) deserves closer scrutiny - US Post News
VRNA Stock Sees Decline of Approximately -3.05% in Last Five Days - Knox Daily
Market Resilience: Verona Pharma Plc ADR (VRNA) Finishes Strong at 29.23, Up 0.14 - The Dwinnex
Is it possible to buy Verona Pharma Plc ADR(VRNA) shares at a good price now? - US Post News
What is Verona Pharma Plc ADR (VRNA) Stock Return on Shareholders’ Capital? - SETE News
Verona Pharma Plc ADR (VRNA) receives a Buy rating from Jefferies - Knox Daily
The Future of Verona Pharma Plc ADR: Analyzing VRNA - The InvestChronicle
You might want to take a look at Verona Pharma Plc ADR (VRNA) now - SETE News
Verona Pharma stock soars to all-time high of $29 amid robust gains - Investing.com UK
Gaining Ground: Verona Pharma Plc ADR (VRNA) Closes Higher at 28.04, Up 2.00 - The Dwinnex
How should investors view Verona Pharma Plc ADR (VRNA)? - US Post News
Wall Street Analyst Resumed Verona Pharma Plc ADR [VRNA]. What else is Wall St. saying - The DBT News
Insider’s View: Deciphering Verona Pharma Plc ADR (VRNA)’s Financial Health Through Ratios - The Dwinnex
Verona Pharma Plc ADR Inc. (VRNA) Price Performance: The Role of Supply and Demand - The InvestChronicle
A stock that deserves closer examination: Verona Pharma Plc ADR (VRNA) - US Post News
Verona Pharma Plc ADR (VRNA) gets rating Resumed from Jefferies - Knox Daily
Investing in MongoDB Inc (MDB): What You Must Know - Knox Daily
2 Standout Biotech Stocks With 32% To 63% Upside - Barchart
An Analysis of Verona Pharma Plc ADR (VRNA)’s Potential Price Growth - Knox Daily
Check Out Verona Pharma Plc ADR (VRNA)’s Trade Data Rather Than the Analysts’ Views - SETE News
Verona Pharma Plc ADR [VRNA] stock for 1,275,681 USD was sold by ZACCARDELLI DAVID - Knox Daily
Market Insights: Verona Pharma Plc ADR (VRNA)’s Notable Drop of -0.54, Closing at 27.47 - The Dwinnex
Verona Pharma Plc ADR (VRNA)’s stock price range in the last year - US Post News
Taking the lead: Verona Pharma Plc ADR (VRNA) - SETE News
President and CEO ZACCARDELLI DAVID sale 398,400 shares of Verona Pharma Plc ADR [VRNA] - Knox Daily
Verona Pharma CFO sells over $1.2 million in company shares - Investing.com
Ratio Review: Analyzing Verona Pharma Plc ADR (VRNA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Therealreal Inc (REAL)’s stock rises to 2.52 per share - US Post News
VRNA: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
MINISO Group Holding Limited Unsponsored ADR (MNSO) Trades Flat On The Day: What You Should Know - Yahoo Finance
Earnings call: Verona Pharma reports Q2 2024 with FDA approval of Ohtuvayre - Investing.com Australia
Earnings call: Verona Pharma reports Q2 2024 with FDA approval of Ohtuvayre - Investing.com
Earnings call: Verona Pharma reports Q2 2024 with FDA approval of Ohtuvayre - Investing.com UK
Verona Pharma Plc ADR [VRNA] stock for 71,032 USD was sold by Rickard Kathleen A. - Knox Daily
Li Auto Inc. Sponsored ADR (LI) Advances While Market Declines: Some Information for Investors - Yahoo Finance
An analyst sees good growth prospects for Verona Pharma Plc ADR (VRNA) - SETE News
XPeng Inc. Sponsored ADR (XPEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Ratios Revealed: Decoding Verona Pharma Plc ADR (VRNA)’s Financial Health - The Dwinnex
Verona Pharma Plc ADR (VRNA)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Sea Limited Sponsored ADR (SE) Stock Moves -1.33%: What You Should Know - Yahoo Finance
Li Auto Inc. Sponsored ADR (LI) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
VRNA stock rated a Buy by Jefferies - Knox Daily
Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga
In the Green: Verona Pharma Plc ADR (VRNA) Closes at 22.61, Up/Down -0.53 from Previous Day - The Dwinnex
Verona Pharma Plc Adr Stock (VRNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):